GHK-Cu: Skin, Hair and Topical vs Injectable Use
Fine lines, skin texture and hair
GHK-Cu is a copper peptide people seek for smoother-looking skin and better texture. Hair growth is another attraction, but the result depends on the product and the area being treated.
Small topical studies offer a useful signal. They do not show that injecting GHK-Cu works better, or establish a skin-care dose for injections.
Skin and hair: different questions
Facial wrinkles 40 women · a specific serum
8 weeks Eyebrow hair 18 adults · a 2% serum
12 weeks Amount, frequency and duration depend on the form
| Example | Amount and frequency | Duration |
|---|---|---|
| The Ordinary Multi-Peptide + Copper Peptides 1% serum | A few drops to the face, morning and evening | Ongoing cosmetic routine; no fixed course stated |
| Trusta clinic’s reported injectable use | 1–2 mg under the skin daily | 4–8 weeks, then reassessment |
The serum directions and Trusta clinic’s published example were checked October 12, 2026. These are finished-product instructions versus one clinic’s reported practice. Neither proves injected GHK-Cu improves skin or establishes a safe cycle. There is no percentage-to-injection conversion.
For the serum, the maker advises patch testing, use on unbroken skin and stopping if irritation occurs. For injections, FDA specifically identifies limited human safety information and impurity/immune-response concerns; see the route comparison below.
What GHK-Cu is
GHK is the three-amino-acid sequence glycine–histidine–lysine. GHK-Cu is its copper complex, also known in cosmetic ingredient naming as copper tripeptide-1. It is different from taking a copper supplement, and different derivatives of GHK should not be treated as the same ingredient.
Topical and injectable claims need different evidence
| Compare | Topical skin care | Injected GHK-Cu |
|---|---|---|
| Delivery question | Does this formulation reach the relevant skin layers? | What exposure follows this route and formulation? |
| Useful outcome | A measured skin change versus a suitable control | A clinical benefit established for the injected product |
| Available example | Small facial-formulation trial described below | The topical trial does not evaluate injections |
What the topical study found
A 2016 randomized, double-blind study enrolled 40 women aged 40–65 and evaluated a GHK-Cu serum using a lipid-based carrier over eight weeks. It reported improvements in measured wrinkle parameters against comparator formulations. This is a useful clinical signal, with a small sample and a specific product/delivery system. It does not establish the same result for every serum carrying a copper-peptide label. Primary paper.
Formulation matters even within that experiment: the control lacked both GHK-Cu and its nano-carrier. A finished-product comparison cannot cleanly tell us what every individual ingredient contributed.
Topical vs injectable use
For a skin-care decision, look for the exact ingredient, finished-product instructions and evidence matching your goal. “Contains peptides” is much less informative than a controlled study of the product’s effect on a defined skin measure.
Injected GHK-Cu has different exposure and quality requirements. FDA identifies concerns for injectable GHK-Cu about immune responses, peptide-related impurities and limited human safety information. A topical cosmetic’s use history does not resolve those issues. FDA safety information.
Mechanism of action
Fibroblasts are cells that help build and remodel connective tissue. A foundational experiment found that GHK-Cu stimulated collagen synthesis in fibroblast culture. That supports a biological rationale for skin research, but the concentration in a cell dish is not a face-serum percentage or an injection dose. Original 1988 experiment.
Pharmacokinetics
The sources above do not validate a one-hour human injection half-life, 50% subcutaneous bioavailability or a predictable minutes-to-hours onset. A GHK-Cu curve using assumed rates illustrates those assumptions; it does not model cream penetration or predict when wrinkles change.
Frequently asked questions
Does GHK-Cu regrow hair? A small 2026 split-face study in 18 adults reported improved eyebrow hair count and diameter with a 2% GHK-Cu serum versus vehicle over 12 weeks. That preliminary result is about eyebrows, not established treatment for scalp hair loss or proof for injections. Evidence about AHK-Cu is also about a different copper peptide.
Can I combine it with vitamin C or other skin-care actives? Compatibility depends on the finished formulation, concentrations and pH. Follow product instructions rather than a universal internet rule that all copper peptides must—or must not—be paired with another ingredient.
Is a higher percentage better? A headline percentage may describe a supplier solution or an active complex. Without the formulation and concentration basis, it is not a reliable potency comparison.
How soon should it work? The cited human trial evaluated changes over weeks. It does not promise an immediate or identical effect from another product.
Can it be mixed with other injectable peptides? The topical study establishes neither injectable efficacy nor combination stability. A clear solution or a blend label is not compatibility evidence.
Related compounds & model context
Article citations are linked in the text. Related catalog entries have separate model inputs and source notes, which may include unverified estimates. See our methodology for model assumptions and limitations.